Search
for
Sort by
Research 30 of 112
- Hypothyroidism in Thyroid Carcinoma Follow-up: Orlistat May Inhibit the Absorption of Thyroxine
- Effects of orlistat on serum androgen levels among iranian obese women with polycystic ovarian syndrome
- Hepatotoxicity Secondary to A Drug to Lose Weight, "Orlistat": to take into Account as a Differential Diagnosis
- ORLISTAT
- In vitro assessment of some deodorant ingredients and determination of malodor inhibiting potentials of ascorbic acid, orlistat and mastic gum
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery
- Nutrition Interventions for Obesity
- The Osler Lecture 2012 'Pharmacology 2.0, medicines, drugs and human enhancement'
- Targeting Obesity in PCOS: A Review of Current Pharmacological Interventions and Future Directions
- Hyperandrogenism insulin resistance-acanthosis nigricans syndrome in a female adolescent with migraine: A case report
- Inhibitory Effects of Edible and Medicinal Plant Extracts on the Enzymatic Activity of Pancreatic Lipase
- Η επίδραση της απώλειας βάρους στα επίπεδα της αντιμυλλεριανής ορμόνης σε υπέρβαρες και παχύσαρκες γυναίκες με το σύνδρομο των πολυκυστικών ωοθηκών
- Hair Growth After Gefitinib Treatment
- Polycystic ovary syndrome
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Obesity and the skin
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- Nutritional management in women with polycystic ovary syndrome: A review study
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- The placebo effect and randomized trials: analysis of conventional medicine
- Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study
- The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion